From migraine mechanisms to innovative therapeutic drugs:
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Hagerstown, MD
Lippincott Williams & Wilkins
2005
|
| Series: | Neurology
64,10, Suppl. 2 |
| Subjects: | |
| Physical Description: | 25 S. Ill., graph. Darst. |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV019840094 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 050610s2005 ad|| |||| 00||| eng d | ||
| 035 | |a (OCoLC)61326849 | ||
| 035 | |a (DE-599)BVBBV019840094 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RC392 | |
| 245 | 1 | 0 | |a From migraine mechanisms to innovative therapeutic drugs |c Nabih M. Ramadan guest ed. |
| 264 | 1 | |a Hagerstown, MD |b Lippincott Williams & Wilkins |c 2005 | |
| 300 | |a 25 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Neurology |v 64,10, Suppl. 2 | |
| 650 | 4 | |a Migraine |x Physiological aspects | |
| 650 | 4 | |a Migraine |x Treatment | |
| 700 | 1 | |a Ramadan, Nabih M. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-013165012 | ||
Record in the Search Index
| _version_ | 1804133350587236352 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV019840094 |
| callnumber-first | R - Medicine |
| callnumber-label | RC392 |
| callnumber-raw | RC392 |
| callnumber-search | RC392 |
| callnumber-sort | RC 3392 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)61326849 (DE-599)BVBBV019840094 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00867nam a2200289 cb4500</leader><controlfield tag="001">BV019840094</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050610s2005 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)61326849</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019840094</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC392</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">From migraine mechanisms to innovative therapeutic drugs</subfield><subfield code="c">Nabih M. Ramadan guest ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hagerstown, MD</subfield><subfield code="b">Lippincott Williams & Wilkins</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">25 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Neurology</subfield><subfield code="v">64,10, Suppl. 2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Migraine</subfield><subfield code="x">Physiological aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Migraine</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ramadan, Nabih M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013165012</subfield></datafield></record></collection> |
| id | DE-604.BV019840094 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:07:19Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-013165012 |
| oclc_num | 61326849 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | 25 S. Ill., graph. Darst. |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | Lippincott Williams & Wilkins |
| record_format | marc |
| series2 | Neurology |
| spelling | From migraine mechanisms to innovative therapeutic drugs Nabih M. Ramadan guest ed. Hagerstown, MD Lippincott Williams & Wilkins 2005 25 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Neurology 64,10, Suppl. 2 Migraine Physiological aspects Migraine Treatment Ramadan, Nabih M. Sonstige oth |
| spellingShingle | From migraine mechanisms to innovative therapeutic drugs Migraine Physiological aspects Migraine Treatment |
| title | From migraine mechanisms to innovative therapeutic drugs |
| title_auth | From migraine mechanisms to innovative therapeutic drugs |
| title_exact_search | From migraine mechanisms to innovative therapeutic drugs |
| title_full | From migraine mechanisms to innovative therapeutic drugs Nabih M. Ramadan guest ed. |
| title_fullStr | From migraine mechanisms to innovative therapeutic drugs Nabih M. Ramadan guest ed. |
| title_full_unstemmed | From migraine mechanisms to innovative therapeutic drugs Nabih M. Ramadan guest ed. |
| title_short | From migraine mechanisms to innovative therapeutic drugs |
| title_sort | from migraine mechanisms to innovative therapeutic drugs |
| topic | Migraine Physiological aspects Migraine Treatment |
| topic_facet | Migraine Physiological aspects Migraine Treatment |
| work_keys_str_mv | AT ramadannabihm frommigrainemechanismstoinnovativetherapeuticdrugs |